Gene Symbol | KLF4 |
Entrez ID | 9314 |
Uniprot ID | O43474 |
Description | Kruppel-like factor 4 (gut) |
Chromosomal Location | chr9: 107,484,852-107,490,482 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IDA |
BP |
GO:0006366 |
transcription from RNA polymerase II promoter |
The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
ISS |
BP |
GO:0007500 |
mesodermal cell fate determination |
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed. |
TAS |
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
TAS |
BP |
GO:0009913 |
epidermal cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of an epidermal cell, any of the cells making up the epidermis. |
IEA |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IGI |
BP |
GO:0010629 |
negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IGI |
BP |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling |
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
IEA |
BP |
GO:0014740 |
negative regulation of muscle hyperplasia |
Any process that stops, prevents, or reduces the frequency, rate, or extent of muscle hyperplasia. |
IEA |
BP |
GO:0019827 |
stem cell population maintenance |
The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types. |
ISS |
BP |
GO:0031077 |
post-embryonic camera-type eye development |
The process occurring during the post-embryonic phase whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. |
IEA |
BP |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity |
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
IDA |
BP |
GO:0032270 |
positive regulation of cellular protein metabolic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
IMP |
BP |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion. |
IDA |
BP |
GO:0035019 |
somatic stem cell population maintenance |
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line. |
TAS |
BP |
GO:0035166 |
post-embryonic hemopoiesis |
The stages of blood cell formation that take place after completion of embryonic development. |
IMP |
BP |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
IDA |
BP |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity |
Any process that modulates the frequency, rate or extent of phosphatidylinositol 3-kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an inositol lipid at the 3' position of the inositol ring. |
IEA |
BP |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8. |
IDA |
BP |
GO:0045429 |
positive regulation of nitric oxide biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
IMP |
BP |
GO:0045444 |
fat cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat. |
ISS |
BP |
GO:0045595 |
regulation of cell differentiation |
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features. |
ISS |
BP |
GO:0045892 |
negative regulation of transcription, DNA-templated |
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
IDA |
BP |
GO:0045893 |
positive regulation of transcription, DNA-templated |
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
ISS|NAS |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IGI|IMP|ISS |
BP |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin. |
IMP |
BP |
GO:0048662 |
negative regulation of smooth muscle cell proliferation |
Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation. |
IEA |
BP |
GO:0048679 |
regulation of axon regeneration |
Any process that modulates the frequency, rate or extent of axon regeneration. |
IEA |
BP |
GO:0048730 |
epidermis morphogenesis |
The process in which the anatomical structures of the epidermis are generated and organized. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species. |
IEA |
BP |
GO:0050728 |
negative regulation of inflammatory response |
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
TAS |
BP |
GO:0051247 |
positive regulation of protein metabolic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein. |
IGI |
BP |
GO:0051898 |
negative regulation of protein kinase B signaling |
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
IEA |
BP |
GO:0051973 |
positive regulation of telomerase activity |
Any process that activates or increases the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). |
IDA |
BP |
GO:0060070 |
canonical Wnt signaling pathway |
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
IEA |
BP |
GO:0060761 |
negative regulation of response to cytokine stimulus |
Any process that decreases the rate, frequency, or extent of a response to cytokine stimulus. |
IDA |
BP |
GO:0070301 |
cellular response to hydrogen peroxide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
IEA |
BP |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade |
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IEA |
BP |
GO:0071300 |
cellular response to retinoic acid |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
IEA |
BP |
GO:0071363 |
cellular response to growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. |
IDA |
BP |
GO:0071409 |
cellular response to cycloheximide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloheximide stimulus. Cycloheximide (actidione) is an antibiotic produced by some Streptomyces species which interferes with protein synthesis in eukaryotes. |
IEA |
BP |
GO:0071499 |
cellular response to laminar fluid shear stress |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. |
IMP |
BP |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis |
Any process that decreases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis. |
IDA |
BP |
GO:1901653 |
cellular response to peptide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus. |
IEA |
BP |
GO:1904998 |
negative regulation of leukocyte adhesion to arterial endothelial cell |
Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell. |
IGI |
BP |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production |
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production. |
IDA |
BP |
GO:2000679 |
positive regulation of transcription regulatory region DNA binding |
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. |
IEA |
CC |
GO:0000790 |
nuclear chromatin |
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus. |
IDA |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
IDA|TAS |
CC |
GO:0005719 |
nuclear euchromatin |
The dispersed less dense form of chromatin in the interphase nucleus. It exists in at least two forms, a some being in the form of transcriptionally active chromatin which is the least condensed, while the rest is inactive euchromatin which is more condensed than active chromatin but less condensed than heterochromatin. |
IEA |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IEA |
CC |
GO:0044798 |
nuclear transcription factor complex |
A protein complex, located in the nucleus, that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
IEA |
MF |
GO:0000987 |
core promoter proximal region sequence-specific DNA binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to the core promoter. The transcribed region might be described as a gene, cistron, or operon. |
IDA |
MF |
GO:0001010 |
transcription factor activity, sequence-specific DNA binding transcription factor recruiting |
The function of binding to a specific DNA sequence and recruiting another transcription factor to the DNA in order to modulate transcription. The recruited factor may bind DNA directly, or may be colocalized via protein-protein interactions. |
ISS |
MF |
GO:0001047 |
core promoter binding |
Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for the basal transcription machinery. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
IEA |
MF |
GO:0001077 |
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
IMP |
MF |
GO:0001085 |
RNA polymerase II transcription factor binding |
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II. |
IPI|ISS |
MF |
GO:0001190 |
transcriptional activator activity, RNA polymerase II transcription factor binding |
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, which may be a single protein or a complex, in order to increase the frequency, rate or extent of transcription from an RNA polymerase II promoter. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well. |
IDA |
MF |
GO:0001221 |
transcription cofactor binding |
Interacting selectively and non-covalently with a transcription cofactor, any protein involved in regulation of transcription via protein-protein interactions with transcription factors and other transcription regulatory proteins. Cofactors do not bind DNA directly, but rather mediate protein-protein interactions between regulatory transcription factors and the basal transcription machinery. |
IEA |
MF |
GO:0003700 |
transcription factor activity, sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
NAS |
MF |
GO:0008013 |
beta-catenin binding |
Interacting selectively and non-covalently with the beta subunit of the catenin complex. |
IEA |
MF |
GO:0008270 |
zinc ion binding |
Interacting selectively and non-covalently with zinc (Zn) ions. |
NAS |
MF |
GO:0035014 |
phosphatidylinositol 3-kinase regulator activity |
Modulates the activity of any of the phosphatidylinositol 3-kinases (PI3Ks). Regulatory subunits can link a PI3K catalytic subunit to upstream signaling events and help position the catalytic subunits close to their lipid substrates. |
IEA |
MF |
GO:0042826 |
histone deacetylase binding |
Interacting selectively and non-covalently with the enzyme histone deacetylase. |
IEA |
MF |
GO:0044212 |
transcription regulatory region DNA binding |
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
ISS |
Domain ID | Description |
---|---|
IPR013087 |
Zinc finger C2H2-type |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04550 |
Signaling pathways regulating pluripotency of stem cells |
KEGG |
WP1991 |
SRF and miRs in Smooth Muscle Differentiation and Proliferation |
WikiPathways |
WP2857 |
Mesodermal Commitment Pathway |
WikiPathways |
WP3527 |
Preimplantation Embryo |
WikiPathways |
WP3946 |
White fat cell differentiation |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0000768 |
Congenital Abnormality |
C0018798 |
Congenital Heart Defects |
C0151744 |
Myocardial Ischemia |
C3495559 |
Juvenile Arthritis |
Tissue | Cell Type |
---|---|
appendix |
glandular cells |
bronchus |
respiratory epithelial cells |
colon |
glandular cells |
duodenum |
glandular cells |
esophagus |
squamous epithelial cells |
nasopharynx |
respiratory epithelial cells |
oral mucosa |
squamous epithelial cells |
rectum |
glandular cells |
skin |
keratinocytes |
skin |
Langerhans |
skin |
melanocytes |
skin |
epidermal cells |
stomach |
glandular cells |
vagina |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15308691 |
Jansen et al. |
2004 |
Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22904171 |
Kaur et al. |
2012 |
Differential Gene Expression in Granulosa Cells from Polycystic Ovary Syndrome Patients with and without Insulin Resistance: Identification of Susceptibility Gene Sets through Network Analysis |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
APP |
351 |
P05067 |
0.56 |
HDAC1 |
3065 |
Q13547 |
0.56 |
CDH1 |
999 |
P12830 |
0.63 |
FLNB |
2317 |
O75369 |
0.63 |
RELA |
5970 |
Q04206 |
0.63 |
SMARCA4 |
6597 |
P51532 |
0.63 |
TCEB2 |
6923 |
Q15370 |
0.63 |
TP53 |
7157 |
P04637 |
0.63 |
CUL2 |
8453 |
Q13617 |
0.63 |
HDAC7 |
51564 |
Q8WUI4 |
0.63 |
ELK1 |
2002 |
P19419 |
0.65 |
PPARG |
5468 |
P37231 |
0.65 |
HDAC5 |
10014 |
Q9UQL6 |
0.65 |
VHL |
7428 |
P40337 |
0.68 |
KAT5 |
10524 |
Q92993 |
0.68 |
CTBP1 |
1487 |
Q13363 |
0.76 |
HDAC2 |
3066 |
Q92769 |
0.79 |
KLF6 |
1316 |
Q99612 |
0.83 |
SP1 |
6667 |
P08047 |
0.89 |
CREBBP |
1387 |
Q92793 |
0.90 |
SETD7 |
80854 |
Q8WTS6 |
0.52 |
PRKCD |
5580 |
Q05655 |
0.63 |
RPL31 |
6160 |
P62899 |
0.63 |
AURKA |
6790 |
O14965 |
0.72 |
EP300 |
2033 |
Q09472 |
0.81 |